- Report
- August 2026
- 389 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 385 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 405 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 383 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 467 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 278 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 209 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 284 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 170 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 381 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 371 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 383 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 160 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 220 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 279 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 186 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 181 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 180 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 189 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 233 Pages
Global
From €5246EUR$5,850USD£4,498GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more